Condition
Prostate Hypertrophy
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04288427Not ApplicableRecruiting
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
NCT05834270Not ApplicableCompleted
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
NCT03916536Not ApplicableCompletedPrimary
Holmium Laser Versus Thulium Laser Versus Bipolar Enucleation of the Prostate.
NCT01631149Phase 4CompletedPrimary
Effect of Deep BLock on Intraoperative Surgical Conditions
Showing all 4 trials